Daniel Schacht
@oasisjuenger
ID: 35583001
26-04-2009 22:22:41
39 Tweet
10 Takipçi
38 Takip Edilen
LQTS has had a long history of various Tx, one of the most controversial has been LCSD. Although first trialed in 1973, it was not until 2017 that LCSD was incorporated into guidelines for management. Read on in #JACCEdge: bit.ly/3tWTdfm #CardioTwitter Pratik Doshi, MD
#AHA22 #JACC LBCT SimPub: Moderate-intensity statin was shown to be more effective than common “heart health” or “cholesterol health” supplements at lowering LDL-C. Supplements are no different than placebo. bit.ly/3fwG0pK Luke J. Laffin #CardioTwitter #CardioEd
Here the link to our study examining the effect of first-line ablation vs AAD on AF progression. Thanks to AHA Science for welcoming me back to present the results, and to NEJM for the simultaneous publication. @CCI_CIC @UBCDoM Canadian Heart Rhythm Society CCS nejm.org/doi/full/10.10…
Ever wondered what is the best #anticoagulant is best for #cancer patients with #AFib? #DOAC and #warfarin have similar risks for CVA, ICH, & GIB for #NVAF. bit.ly/3sUdfGo #JACCCardioOnc #CardioOnc #CardioTwitter Adam Potter, MD, PhD, FACC Efstratios Koutroumpakis, MD Anita Deswal Nicolas Palaskas, MD
Another advantage of being a 🇳🇱🧀 in 🇩🇪 … Your birthday-cake is freshly baked by your wonderful colleagues 🙏🏼Daniel Schacht @MarienhospitalA